Kyu-Don Kim

Corporate Officer/Principal presso GENEXINE, INC.

66 anni

Health Technology

Consumer Services

Profilo

Kyu-Don Kim is currently the Director of Operations at PT Kalbe Genexine Biologics and the President of the Executive Board at Genexine, Inc. Previously, he worked as the Vice President, Director, and Head of Management at Chong Kun Dang Pharmaceutical Corp.
in 2014.
He holds a doctorate degree from Northern Illinois University.

Posizioni attive di Kyu-Don Kim

Società	Posizione	Inizio
GENEXINE, INC.	Corporate Officer/Principal	-
PT Kalbe Genexine Biologics PT Kalbe Genexine Biologics BiotechnologyHealth Technology PT Kalbe Genexine Biologics is a clinical-stage biotech company based in Jakarta, Indonesia. The Indonesian company specializes in licensing novel biologics and biosimilars in oncology and high-specialty therapeutic areas, as well as contract manufacturing. The company was founded in 2016 and is backed by Kalbe and Genexine, as well as US private equity giant General. The CEO is Sie Djohan.	Direttore operativo	-

Tutte le posizioni attive di Kyu-Don Kim

Precedenti posizioni note di Kyu-Don Kim

Società	Posizione	Fine
CHONG KUN DANG PHARMACEUTICAL CORP.	Amministratore Delegato	-

Vedi nel dettaglio l'esperienza di Kyu-Don Kim

Formazione di Kyu-Don Kim

Northern Illinois University

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Kyu-Don Kim

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
CHONG KUN DANG PHARMACEUTICAL CORP.	Health Technology
GENEXINE, INC.	Health Technology

Aziende private	1
PT Kalbe Genexine Biologics PT Kalbe Genexine Biologics BiotechnologyHealth Technology PT Kalbe Genexine Biologics is a clinical-stage biotech company based in Jakarta, Indonesia. The Indonesian company specializes in licensing novel biologics and biosimilars in oncology and high-specialty therapeutic areas, as well as contract manufacturing. The company was founded in 2016 and is backed by Kalbe and Genexine, as well as US private equity giant General. The CEO is Sie Djohan.	Health Technology